Results
eNauka >
Results >
Serological response to MAG1 and serotype signature predict reactivation risk and clinical severity after HSCT
| Title: | Serological response to MAG1 and serotype signature predict reactivation risk and clinical severity after HSCT | Authors: | Štajner, Tijana   ; Viscidi, R.; Lijeskić, Olivera ; Zlatković, Đorđe ; Bauman, Neda ; Srbljanović, Jelena ; Xiao, J. |
Issue Date: | 2026 | Publication: | 18th International Congress on Toxoplasmosis, June 14th-17th 2026, Buzios, Rio de Janeiro, Brazil : Abstract Book | Type: | Conference Paper | Collation: | str. 9-9 | URI: | https://rimi.imi.bg.ac.rs/handle/123456789/1844 https://enauka.gov.rs/handle/123456789/1049510 |
Project: | ToxoReTREAT - Reinvention of the diagnostic algorithm and treatment options for reactivated toxoplasmosis Ministarstvo nauke, tehnološkog razvoja i inovacija Republike Srbije, institucionalno finansiranje - 200015 (Univerzitet u Beogradu, Institut za medicinska istraživanja) |
M-category: | Mp. category will be shown later |
Google ScholarTM
Items in eNauka are protected by copyright, with all rights reserved, unless otherwise indicated.